Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 03 - 09 tags : Cancer save search
Vaccinex, Inc. Announces Upcoming Presentation at the 2022 American Association for Cancer Research Meeting Updating the Phase 1b Segment of the KEYNOTE-B84 Study of Pepinemab in Combination with KEYTRUDA (pembrolizumab) in Patients with Recurrent or Meta
Published: 2022-03-09 (Crawled : 16:20) - ir.vaccinex.com
VCNX | $4.9631 -2.76% 3.5K
|
Health Technology
|
| O: 1.83%
H: 18.92%
C: 17.12%
america ema phase 1b research presentation pepinemab phase 1 keytruda dating cancer vaccine phase 2b
Vaccinex, Inc. Announces Upcoming Presentation at the 2022 American Association for Cancer Research Meeting Updating the Phase 1b Segment of the KEYNOTE-B84 Study of Pepinemab in Combination with KEYTRUDA (pembrolizumab) in Patients with Recurrent or Metastatic Head and Neck Cancer
Published: 2022-03-09 (Crawled : 23:00) - globenewswire.com
VCNX | $4.9631 -2.76% 3.5K
|
Health Technology
|
| O: 1.83%
H: 18.92%
C: 17.12%
america ema phase 1b research presentation pepinemab phase 1 keytruda dating cancer head and neck vaccine phase 2b
Guardant Health to Present New Data from its Broad Portfolio of Blood Tests at the American Association for Cancer Research Annual Meeting
Published: 2022-03-09 (Crawled : 22:00) - biospace.com/
GH | News 4 | $18.1 4.38% 4.2% 1.6M
|
Health Services
|
| O: 2.71%
H: 5.58%
C: 4.56%
america health blood research test cancer
I-Mab Announces Multiple Presentations at the 2022 American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-03-09 (Crawled : 22:00) - biospace.com/
IMAB | $1.805 0.28% 0.28% 110K
|
Health Technology
|
| O: 4.24%
H: 3.69%
C: 2.92%
america research presentation cancer
GT Biopharma Presented Preclinical Data Demonstrating Novel Mesothelin-Targeted TriKE® Driving Cytotoxicity Across All Stages of Non-Small Cell Lung Cancer at ESMO TAT 2022
Published: 2022-03-09 (Crawled : 22:00) - prnewswire.com
GTBP | $3.65 -2.44% 370
|
Manufacturing
|
| O: 3.03%
H: 0.0%
C: -6.18%
trike biopharma cel preclinical lung cancer cancer pre-clinical
Skin Cancer Cells - As they Spread to the Brain - use an Alzheimer's Protein to Sabotage Immune Defenses
Published: 2022-03-09 (Crawled : 20:00) - prnewswire.com
FNCTF | News | $11.16 -20.84% 130
|
Communications
|
| O: 2.75%
H: 0.0%
C: 0.0%
alzheimer skin cel defense skin cancer cancer alzheimer’s alzheimer's train
The Worldwide Cancer Pain Industry is Expected to Reach $9.9 Billion by 2030
Published: 2022-03-09 (Crawled : 17:00) - prnewswire.com
TEVA | $13.01 -0.68% 7.5M
|
Health Technology
|
| O: 2.57%
H: 4.49%
C: 3.17%
SRNE | $0.015 -8.85% 56K
|
Health Technology
|
| O: 2.4%
H: 10.33%
C: 8.45%
cancer
Shattuck Labs to Present Two Posters at the 2022 American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-03-09 (Crawled : 13:30) - globenewswire.com
STTK | $9.87 4.0% 3.85% 230K
|
Health Technology
|
| O: 0.0%
H: 1.07%
C: 0.85%
america pos research cancer
TYME Technologies, Inc. Announces SM-88 Poster at the American Association for Cancer Research (AACR) Annual Meeting 2022
Published: 2022-03-09 (Crawled : 12:00) - globenewswire.com
TYME | $0.3107 -8.21%
|
Health Technology
|
| O: 4.35%
H: 4.83%
C: 4.0%
sm-88 america pos research cancer
Bispecific Antibodies for Cancer Market will Register 6.44% YOY Growth in 2022 | 39% Growth to Originate from North America| 17,000+ Technavio Reports
Published: 2022-03-09 (Crawled : 08:00) - prnewswire.com
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: -2.55%
H: 1.28%
C: 0.19%
FSTX | $7.12 0.0% 0
|
Health Technology
|
| O: 8.24%
H: 1.25%
C: -1.99%
MRUS | $41.96 2.79% 2.72% 740K
|
Health Technology
|
| O: 0.5%
H: 5.19%
C: 4.84%
MREO | $2.785 0.18% 0.18% 570K
|
Health Technology
|
| O: 16.67%
H: 4.76%
C: -0.68%
APVO | $0.6827 -7.27% -7.84% 570K
|
Health Technology
|
| O: -2.6%
H: 10.68%
C: 4.31%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.81%
H: 0.13%
C: -1.18%
AFMD | $4.91 -8.22% -8.96% 65K
|
Health Technology
|
| O: 2.39%
H: 7.24%
C: 6.07%
america origin report cancer growth antibody
Caribou Biosciences to Present Preclinical Data on CB-011, an Immune-Cloaked Allogeneic Anti-BCMA CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-03-09 (Crawled : 02:00) - globenewswire.com
CRBU | $3.86 -3.02% -3.11% 1.1M
|
Health Technology
|
| O: 4.28%
H: 5.05%
C: 2.74%
cb-011 america car-t research cel preclinical therapy bioscience cancer t-cell pre-clinical
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.